Successful Induction of Tumor‐specific Cytotoxic T Lymphocytes from Patients with Non‐small Cell Lung Cancer Using CD80‐transfected Autologous Tumor Cells
- 1 March 2001
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 92 (3), 309-315
- https://doi.org/10.1111/j.1349-7006.2001.tb01096.x
Abstract
Cytotoxic T lymphocytes (CTL) against human lung cancer cells are difficult to induce by a conventional method using tumor cell stimulation probably due to an insufficiency of tumor antigens (TA) or costimulatory molecules such as CD80. We, therefore, investigated the potential of CD80‐transfected tumor cells as stimulators of the in vitro induction of autologous tumor‐specific CTL from regional lymph node lymphocytes in patients with lung cancer. Five non‐small cell lung cancer cell lines (two adenocarcinomas, 1 squamous cell carcinoma, 1 large cell carcinoma and 1 adenosquamous cell carcinoma) were established from surgical specimens and were successfully transduced with a plasmid constructed with expression vector pBj and human CD80 cDNA, using a lipofection method. CD80‐transfected tumor cells (CD80‐AT) significantly augmented the proliferation of autologous lymphocytes from all cases as compared with non‐transfected tumor cells (AT). AT‐stimulated lymphocytes from 4 out of 5 cases did not show any cytotoxicity against AT; however, lymphocytes stimulated with CD80‐AT exhibited substantial cytotoxicity against parental AT in all 5 cases tested. AT‐stimulated lymphocytes derived from only one out of 5 cases showed major histocompatibility complex (MHC)‐class I‐restricted cytokine production in response to AT, while the MHC‐class I‐restricted responses were found in CD80‐AT‐stimulated lymphocytes from 4 out of 5 cases. These results indicate that CD80 on tumor cells could be a beneficial costimulatory molecule to elicit CTL against lung cancer, and also show that TA recognized by CTL was frequently expressed on lung cancer cells.Keywords
This publication has 29 references indexed in Scilit:
- A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer AntigensImmunity, 1999
- Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.1998
- Autologous Tumor‐specific Cytotoxic T Lymphocytes in a Patient with Lung Adenocarcinoma: Implications of the Shared Antigens Expressed in HLA‐A24 Lung Cancer CellsJapanese Journal of Cancer Research, 1998
- T cell defined tumor antigensCurrent Opinion in Immunology, 1997
- Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?Nature Medicine, 1996
- Expression of CD80 Enhances Immunogenicity of Cervical Carcinoma Cellsin VitroCellular Immunology, 1996
- Review of the curative role of radiotherapy in the treatment of non-small cell lung cancerLung Cancer, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.The Journal of Immunology, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991